Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ANKRD33B pseudogene 2 is annotated as a pseudogene related to the ANKRD33B (ankyrin repeat domain 33B) gene in humans. Pseudogenes are genomic sequences similar to known genes but generally lack protein-coding potential and are not translated into functional proteins. As such, this locus does not encode a functional protein and is not a known therapeutic target or disease-related gene. There is no evidence from available gene function databases that ANKRD33BP2 plays an active or regulatory role in cellular physiology or disease; its inclusion in databases is likely limited to genome annotation without any recognized molecular or pathological function.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ANKRD33B pseudogene 2 (ANKRD33BP2).